Medical Director, Breast Cancer Research Program
I am a medical oncologist at Memorial Healthcare System with board certifications in medical oncology, hematology and internal medicine. I care for patients at Memorial Cancer Institute who are battling various stages of breast cancer.
Oncology is a rapidly changing field, where new developments and treatment options are continually being discovered. I consider it a critical part of my job to stay up to date on the latest findings. I am also actively involved in clinical trials and research at Memorial Cancer Institute, which means our patients have access to new drugs that are not yet offered nationwide. I am proud to be making a difference in the lives of my patients and bringing us all closer to a cure.
Throughout my career at Memorial, I have been able to participate as a principal investigator in many clinical trials that have led to the discovery of new therapies in the battle against breast cancer. Memorial Cancer Institute offers the technical advances necessary to receive the best cancer therapy in South Florida, along with the compassion necessary to care for patients going through the difficult journey of cancer treatment. I feel very fortunate to be a part of this community and this great organization.
While the technical sides of my job are crucial, I never forget that my main purpose is to help my patients during a very difficult time in their life. I want all my patients to feel comfortable communicating with me, to know that I will listen to everything they have to say and that together we will find the right treatment options that will give them the best quality of life.
Universidad De Panama, 2000
Jackson Memorial Hospital/Jackson Health System, 2004
Jackson Memorial Hospital, 2006, Internal Medicine
Jackson Memorial Hospital, 2009, Oncology
Awards, Achievements, and More
At Memorial Cancer Institute, I am a principle investigator and participant in clinical trials and research aimed at finding new treatment options and a cure for breast cancer. These trials explore new drugs, treatment protocols and side effects of breast cancer treatment.
Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients with Early-Stage HER2+ Breast Cancer Treated with Neratinib and Intensive Loperamide Prophylaxis
- SWOG S1207
Phase III Randomized, Placebo-Controlled Clinical
Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and
HER2/neu Negative Breast Cancer.
- ONT-380-206 (HER2CLIMB)
Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib vs. Placebo in Combination with Capecitabine and Trastuzumab in Patients with Pretreated Unresectable Locally Advanced or Metastatic HER2+ Breast Carcinoma
- American Society of Clinical Oncology
- American Society of Hematology
- American College of Physicians
- Hispanic Heritage Month Community service award 2021, given by the city of Miramar
- 3 times recipient of the Press Ganey “Guardian of excellence award” in 2016, 2018, 2019
- Eric Reiss Award for Excellent Teaching Resident, Jackson Memorial Hospital, 2005